|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2006-2-1
|
|
pubmed:abstractText |
Recent data suggest that atenolol may be inferior to other antihypertensive drugs in reducing cardiovascular risk in older individuals with hypertension, despite lowering peripheral blood pressure (BP). We hypothesized that that atenolol fails to reduce central BP as much as other agents. The aim of the present study was to compare the hemodynamic effects of atenolol and eprosartan in a double-blind, randomized, cross-over study.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0895-7061
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
19
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
214-9
|
|
pubmed:dateRevised |
2009-2-24
|
|
pubmed:meshHeading |
pubmed-meshheading:16448896-Acrylates,
pubmed-meshheading:16448896-Antihypertensive Agents,
pubmed-meshheading:16448896-Aorta, Thoracic,
pubmed-meshheading:16448896-Atenolol,
pubmed-meshheading:16448896-Blood Pressure,
pubmed-meshheading:16448896-Cross-Over Studies,
pubmed-meshheading:16448896-Double-Blind Method,
pubmed-meshheading:16448896-Electrocardiography,
pubmed-meshheading:16448896-Female,
pubmed-meshheading:16448896-Follow-Up Studies,
pubmed-meshheading:16448896-Humans,
pubmed-meshheading:16448896-Hypertension,
pubmed-meshheading:16448896-Imidazoles,
pubmed-meshheading:16448896-Male,
pubmed-meshheading:16448896-Middle Aged,
pubmed-meshheading:16448896-Prospective Studies,
pubmed-meshheading:16448896-Pulsatile Flow,
pubmed-meshheading:16448896-Receptor, Angiotensin, Type 1,
pubmed-meshheading:16448896-Thiophenes,
pubmed-meshheading:16448896-Treatment Outcome
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Atenolol and eprosartan: differential effects on central blood pressure and aortic pulse wave velocity.
|
|
pubmed:affiliation |
Clinical Pharmacology Unit, University of Cambridge, Addenbrooke's Hospital, Cambridge, England.
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial
|
